检验医学 ›› 2024, Vol. 39 ›› Issue (8): 738-742.DOI: 10.3969/j.issn.1673-8640.2024.08.004

• 论著 • 上一篇    下一篇

食管癌患者血清miR-134和miR-149表达及其临床意义

高金锁   

  1. 合肥市第三人民医院肿瘤血液科,安徽 合肥 230022
  • 收稿日期:2023-02-08 修回日期:2024-06-11 出版日期:2024-08-30 发布日期:2024-09-02
  • 作者简介:高金锁,男,1972年生,硕士,副主任医师,主要从事肿瘤综合治疗工作。

Expression and clinical significance of serum miR-134 and miR-149 in patients with esophageal cancer

GAO Jinsuo   

  1. Department of Oncology,the Third People's Hospital of Hefei,Hefei 230022,Aihui,China
  • Received:2023-02-08 Revised:2024-06-11 Online:2024-08-30 Published:2024-09-02

摘要:

目的 探讨食管癌患者血清miR-134和miR-149的表达及其临床意义。方法 选取2020年4月—2022年10月合肥市第三人民医院食管癌患者132例(食管癌组)、食管良性疾病患者125例(良性对照组)和健康体检者130名(正常对照组)。收集所有研究对象的一般资料,并检测血清miR-134、miR-149相对表达量和癌胚抗原(CEA)、糖类抗原(CA)125、CA72-4水平。采用Pearson相关分析评估血清miR-134、miR-149与CEA、CA125、CA72-4的相关性。采用受试者工作特征(ROC)曲线评价血清miR-134、miR-149单项检测和联合检测诊断食管癌的效能。结果 食管癌组血清miR-134相对表达量和CEA、CA125、CA72-4水平均高于良性对照组、正常对照组(P<0.05),良性对照组均高于正常对照组(P<0.05);食管癌组miR-149相对表达量均低于良性对照组和正常对照组(P<0.05),良性对照组miR-149相对表达量低于正常对照组(P<0.05)。食管癌组CEA、CA125和CA72-4阳性率均高于良性对照组和正常对照组(P<0.05)。不同肿瘤直径、分化程度和有无淋巴转移的食管癌患者之间血清miR-134、miR-149相对表达量差异均有统计学意义(P<0.05)。食管癌患者血清miR-134与CEA、CA125、CA72-4均呈正相关(r值分别为0.425、0.419、0.457,P<0.001),血清miR-149与CEA、CA125、CA72-4均呈负相关(r值分别为-0.529、-0.534、-0.458,P<0.001)。ROC曲线分析结果显示,血清miR-134、miR-149单项检测诊断食管癌的AUC分别为0.768、0.773,miR-134+miR-149的AUC为0.910,CEA+CA125+CA 72-4的AUC为0.901,5项指标联合检测的AUC为0.916。结论 食管癌患者血清miR-134、miR-149均呈异常表达,且与病情密切相关,或可作为食管癌辅助诊断和病情监测的指标。

关键词: miR-134, miR-149, 食管癌, 临床病理特征

Abstract:

Objective To investigate the expression and clinical significance of serum miR-134 and miR-149 in patients with esophageal cancer. Methods From April 2020 to October 2022,132 patients with esophageal cancer(esophageal cancer group),125 patients with benign esophageal diseases(benign control group) and 130 healthy subjects(healthy control group) were enrolled from the Third People's Hospital of Hefei. The general data of all the subjects were collected,and the relative expression levels of miR-134 and miR-149 and the levels of carcinoembryonic antigen(CEA),carbohydrate antigen(CA) 125 and CA72-4 in serum were determined. Pearson correlation analysis was used to evaluate the correlation between serum miR-134,miR-149 and CEA,CA125,CA72-4. The efficacy of serum miR-134 and miR-149 single and combined determination in the diagnosis of esophageal cancer was evaluated by receiver operating characteristic(ROC) curve. Results The relative expression level of miR-134 and the levels of CEA,CA125 and CA72-4 in serum in esophageal cancer group were higher than those in benign control group and healthy control group(P<0.05),and those in benign control group were higher than those in healthy control group(P<0.05). The relative expression of miR-149 in esophageal cancer group was lower than those in benign control group and healthy control group(P<0.05),and that in benign control group was lower than that in healthy control group(P<0.05). The positive rates of CEA,CA125 and CA72-4 in esophageal cancer group were higher than those in benign control group(P<0.05). There was statistical significance in the relative expression levels of serum miR-134 and miR-149 among esophageal cancer patients with different tumor diameters,differentiation degrees and lymphatic metastasis(P<0.05). Serum miR-134 was positively correlated with CEA,CA125 and CA72-4 in patients with esophageal cancer(r values were 0.425,0.419 and 0.457,P<0.001). Serum miR-149 was negatively correlated with CEA,CA125 and CA72-4(r values were -0.529,-0.534 and -0.458,P<0.001). The areas under curves(AUC) of serum miR-134 and miR-149 in the diagnosis of esophageal cancer were 0.768 and 0.773,respectively. The AUC of miR-134+miR-149,CEA+CA125+CA72-4,miR-134+miR-149+CEA+CA125+CA72-4 were 0.910,0.901,0.916,respectively. Conclusions Serum miR-134 and miR-149 are abnormally expressed in patients with esophageal cancer,which are related to the disease,and they may be used as indicators for auxiliary diagnosis and disease monitoring of esophageal cancer.

Key words: MiR-134, MiR-149, Esophageal cancer, Clinicopathological characteristic

中图分类号: